Drug Patent Expirations for the week of November 22, 2015
DITROPAN XL (oxybutynin chloride)
Janssen pharms
Patent: 5,840,754
Expiration: Nov 22, 2015
DITROPAN XL (oxybutynin chloride)
Janssen pharms
Patent: 5,912,268
Expiration: Nov 22, 2015
DITROPAN XL (oxybutynin chloride)
Janssen pharms
Patent: 5,674,895
Expiration: Nov 22, 2015
DITROPAN XL (oxybutynin chloride)
Janssen pharms
Patent: 6,262,115
Expiration: Nov 22, 2015
LETAIRIS (ambrisentan)
Gilead
Patent: 5,840,722
Expiration: Nov 24, 2015
CLINOLIPID 20% (olive oil; soybean oil)
Baxter hlthcare
Patent: 5,840,757
Expiration: Nov 24, 2015
ORBACTIV (oritavancin diphosphate)
The medicines co
Patent: 5,840,684
Expiration: Nov 24, 2015
THYROGEN (thyrotropin alfa)
Genzyme
Patent: 5,840,566
Expiration: Nov 24, 2015